AMRE News Alert Amreit Inc (AMRE) 26.53 12/25/2014 18:53:29

New Post Public Reply Private Reply Replies (0) Message Board

Dec 25, 2014 at 7:53 PM

Amreit Inc (AMRE) 26.53 $AMRE

5 Best Performing Russell 2000 Stocks of 2014 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 1:14PM CST
The Russell 2000 Index has lagged all the major benchmarks for most part of this year but has managed to post modest year-to-date gains, thanks to the favorable economic environment prevailing on the domestic front.
AMRE: 26.53 (-0.01), UEIC: 63.97 (+0.53), SKH: 8.73 (-0.02), FLWS: 8.07 (+0.18), GTIV: 19.07 (unch)

AMREIT, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Mon Dec 01, 11:40AM CST
Rigrodsky & Long, P.A.:
AMRE: 26.53 (-0.01)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of AmREIT, Inc. in Connection with the Sale of the Company
Business Wire - Wed Nov 26, 5:05PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of AmREIT, Inc. ("AmREIT" or the "Company"

(NYSE: AMRE) relating to the proposed acquisition by Edens Investment Trust. ("Edens"

.
AMRE: 26.53 (-0.01)

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of AmREIT Inc. And Encourages Investors To Contact The Firm For Additional Information
Business Wire - Mon Nov 24, 4:36PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of AmREIT Inc. ("AmREIT" or the "Company"

(NYSE: AMRE) by Edens Investment Trust ("Edens"

, a private company.
AMRE: 26.53 (-0.01)

The Macerich Company (MAC) Catches Eye: Stock Jumps 9.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 20, 8:11AM CST
The Macerich Company (MAC) was a big mover last session, as the company saw its shares rise nearly 10% on the day.
DDR: 18.49 (-0.01), AMRE: 26.53 (-0.01), CBL: 19.72 (-0.19), MAC: 83.33 (-0.21)

AMRE SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of AmREIT, Inc. in Connection With the Fairness of the Sale of the Company to Edens Investment Trust - AMRE
PR Newswire - Tue Nov 18, 10:27AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of AmREIT, Inc. (NYSE: AMRE) ("AmREIT"

in connection with the sale of the Company to Edens Investment Trust.
AMRE: 26.53 (-0.01)

AMREIT, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of AmREIT, Inc. (AMRE) Over the Proposed Sale of the Company to Edens Investment Trust
PR Newswire - Thu Nov 06, 3:42PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of AmREIT, Inc. ("AmREIT" or the "Company"

(NYSE:AMRE) for potential breaches of fiduciary duties in connection with the sale of the Company to Edens Investment Trust ("Edens"

for approximately $763 million. The Company's stockholders will receive $26.55 for each share of AmREIT common stock they own.
AMRE: 26.53 (-0.01)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation of the Board of Directors of AmREIT, Inc. in Connection With the Fairness of the Sale of the Company to Edens Investment Trust
Business Wire - Thu Nov 06, 2:48PM CST
Levi & Korsinsky is investigating the Board of Directors of AmREIT, Inc. ("AmREIT" or "the Company"

(NYSE:AMRE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Edens Investment Trust.
AMRE: 26.53 (-0.01)

Robbins Arroyo LLP: Acquisition of AmREIT Inc. (AMRE) by Edens Investment Trust May Not Be in Shareholders' Best Interests
PR Newswire - Wed Nov 05, 7:10PM CST
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of AmREIT Inc. (NYSE: AMRE) by Edens Investment Trust, a private company. On October 31, 2014, AmREIT announced the signing of a definitive merger agreement pursuant to which Edens will acquire all the outstanding shares of AmREIT for $26.55 per share in cash.
AMRE: 26.53 (-0.01)

Lifshitz & Miller Law Firm Announces Investigation of AmREIT, Inc., Digital River, Inc., Greater Sacramento Bancorp., Hampden Bancorp, Inc., Integrity Bancshares, Inc., Retrophin, Inc. and Sapient Corp.
PR Newswire - Wed Nov 05, 11:33AM CST
AmREIT, Inc.
HBNK: 20.95 (+0.10), DRIV: 24.49 (+0.09), AMRE: 26.53 (-0.01), SAPE: 24.81 (-0.01), RTRX: 12.92 (+0.19)

AmREIT Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Edens Investment Trust
Business Wire - Tue Nov 04, 10:56AM CST
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of AmREIT, Inc. ("AmREIT"

(NYSE: AMRE) concerning the acquisition by Edens Investment Trust. Under the terms of the agreement AmREIT shareholders will only receive $26.55 in cash per AmREIT share owned.
AMRE: 26.53 (-0.01)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of AmREIT, Inc. Concerning its Proposed Sale to Edens Investment Trust - AMRE
Business Wire - Tue Nov 04, 10:55AM CST
The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of AmREIT, Inc. (NYSE: AMRE) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop AmREIT to maximize shareholder value before agreeing to be acquired by Edens Investment Trust.
AMRE: 26.53 (-0.01)

AMRE INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation into the Board of Directors of AmREIT, Inc. Regarding the Fairness of the Sale of the Company to Edens Investment Trust -- AMRE
PR Newswire - Tue Nov 04, 10:40AM CST
Levi & Korsinsky is investigating the Board of Directors of AmREIT, Inc. ("AmREIT" or "the Company"

(NYSE: AMRE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Edens Investment Trust.
AMRE: 26.53 (-0.01)

AmREIT Inc declares $0.20 dividend
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 7:39AM CST

AMRE: 26.53 (-0.01)

AmREIT Reports Third Quarter Results and Declares December 2014 Dividend
Business Wire - Tue Nov 04, 7:31AM CST
AmREIT, Inc. (NYSE:AMRE) ("AmREIT" or the "Company"

today announced financial results for the third quarter ended September 30, 2014 and declared dividends for the fourth quarter ending December 31, 2014.
AMRE: 26.53 (-0.01)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of AmREIT, Inc. in Connection with the Sale of the Company -AMRE
PR Newswire - Mon Nov 03, 8:35PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of AmREIT, Inc.. ("AmREIT" or the "Company"

(NYSE -AMRE-News) relating to the proposed acquisition by Edens Investment Trust. ("Edens"

.
AMRE: 26.53 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BAC Faces Securities Fraud Lawsuit: What Investors Need

An Investor's Battle with Bank of America Bank of America Corporation, or as Wall Street folks call it, BAC, is under the microscope thanks to a securities fraud lawsuit that’s beginning to stir the pot. This lawsuit has caught the attention of the litigators at Schall, Brown & Schwartz LLP, who are sharp enough to smell opportunity where the rest of us sense chaos....

MIAX Preps New Binary Options Amid SEC Filings

MIAX's Strategic Move Towards Binary Options Ah, that's something that might just shake things up a bit. On November 3rd, 2026, MIAMI International Holdings (NYSE: MIAX) made the headlines by filing with the SEC to offer cash-settled binary index options. Now, if you're not new to the trading game, you know that anything involving SEC registration gets the blood pumping....

Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Tokenized Securities: Transfer Online's Next Frontier

Transfer Online Teams Up with OnchainTA Hold onto your investment hats, folks—Transfer Online is linking arms with OnchainTA to step right into the future playground of tokenized securities. Now, what's that mean? Well, it's like jumping from sailing schooners to speedboats; we're entering a whole new era in capital markets. What's At Stake? The pair-up between these...

Zayne Burgess Accelerates Towards Formula 1 with K1 Speed

A Young Racer's Roaring Start Every once in a while, a kid shows up on the scene who just makes you sit up and pay attention. Enter Zayne Burgess, a mere 10-year-old with the skill set of a seasoned pro. If you care about the future of racing, you better start watching this young'un, because he's chasing a Formula 1 dream and has K1 Speed putting their chips on him....

Are BWIN, LFCR, PCRX Shareholder Deals Fair?

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

SportsMed Expands to 58 Clinics, New Opening in Jersey City

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Minghui and ASKA Seal Major Licensing Deal for MHB018A

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Montefiore Einstein Takes On Breast Cancer's Hidden Battle

Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...

Orlando's Holiday Extravaganza: Theme Parks to Unique Festivities

Holiday Cheer Abounds in Orlando Orlando's never a letdown when it comes to spectacle, but this holiday season, they've taken it up a notch and a half. The city's bursting with festivities, from the iconic theme parks to lively local events that offer something for everyone. Whether you're entertaining kids or looking for grown-up glitz, Orlando's got you sorted. Merry...